Cochrane Library Podcasts

In May 2022, Cochrane published the first version of an overview and network meta-analysis of interventions for heavy menstrual bleeding, which can affect 20% to 50% of people who menstruate during their reproductive years. There are a variety of treatments available, each with its pros and cons, and the best treatment is likely to depend on several factors, including age, desire to have children, personal preferences and medical history.

Insomnia affects many people and a wide range of approaches are taken to try to help with it. One of these involves listening to music and the relevant Cochrane Review was updated in August 2022. Here's lead author, Kira Vibe Jespersen from Aarhus University and The Royal Academy of Music Aarhus/Aalborg in Denmark to tell us about the importance of the review and what it found.

Cochrane has produced a series of reviews relevant to the COVID-19 pandemic and is keeping these up-to-date in light of new evidence. In November 2022, we published the second version of a living systematic review on systemic corticosteroids and, in this podcast, the first authors, Mirko Griesel of the University of Leipzig Medical Center and Carina Wagner of the University Hospital in Cologne in Germany, talk about the evidence they’ve found and the potential effects of these drugs.

The intravenous administration of fluids and drugs, and the drawing of blood samples requires the placing of a catheter or cannula into a vein using a needle in a procedure known as peripheral intravenous cannulation. There are different ways to guide the procedure and a new Cochrane Review from December 2022 looks at the effect of using ultrasound guidance. In this podcast, Edoardo Ostinelli from the University of Oxford talks with lead author Masafumi Tada from Kyoto University in Japan, about the review.

Low-back pain is a very common problem, and a variety of treatments have been assessed in Cochrane Reviews. In November 2022, we published an update of the 2017 Cochrane review of the effects of yoga for chronic, non-specific low-back pain. The review was led by Susan Wieland of the Cochrane Complementary Medicine Field in the USA, together with colleagues from Canada, Germany and the UK. Here’s another of the authors on the review, Shireen Harbin from the Institute for Work & Health in Toronto Canada to tell us about the latest findings.

Osteoarthritis is the commonest type of arthritis and there are Cochrane reviews for many interventions that might be used to treat it. These were added to in October 2022 with a new review of the effects of using adjunctive therapies along with land-based exercise therapy for osteoarthritis of the hip or knee. In this podcast, podcast editor Mike Clarke speaks with lead author Helen French from the Royal College of Surgeons in Ireland, about the importance of the review and its findings.

Most Cochrane Reviews look at the effects of interventions on health, but a growing number provide evidence on how to diagnose a disease. In September 2022, one of these diagnostic test accuracy reviews was updated for a test used to detect tuberculosis in children. The lead author, Alex Kay (left), and co-author, Tara Ness, from the Texas Children’s Hospital in Houston in the USA, tell us about the importance of the review and its latest findings in this podcast.

Many people with heart or vascular problems also have high blood pressure, and the latest update of the Cochrane Review of using blood pressure targets in their treatment was published in November 2022. Here's lead author, Luis Carlos Saiz from the Navarre Health Service in Pamplona Spain, to tell us about the review and its latest findings.

Some patients who take pharmaceutical opioids to treat pain become dependent on them and might need to switch to medications such as opioid agonists. In September 2022, an updated Cochrane Review brought together the relevant evidence and, in this podcast, Addiction Psychiatrist Shalini Arunogiri from Monash University and Turning Point in Melbourne talks with lead author, Suzanne Nielsen (or Suzi) from the Monash Addiction Research Centre in Australia.

The Cochrane Skin Group has produced some of the largest Cochrane reviews, providing a “one stop shop” for people interested in a wide range of interventions for a particular skin condition. One such example is the review of systemic medicines to treat psoriasis, which was updated for the fourth time in May 2022. We asked two of the authors, Laurence Le Cleach, head of the French satellite of the Cochrane Skin group and dermatologist at Henri Mondor hospital, AP-HP in France and Emilie Sbidian, a dermatologist working at the same hospital, to describe the findings.